Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.
Identifieur interne : 000960 ( PubMed/Corpus ); précédent : 000959; suivant : 000961Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.
Auteurs : Thales R. Cipriani ; Ana Helena P. Gracher ; Lauro M. De Souza ; Roberto J C. Fonseca ; Celso L R. Belmiro ; Philip A J. Gorin ; Guilherme L. Sassaki ; Marcello IacominiSource :
- Thrombosis and haemostasis [ 0340-6245 ] ; 2009.
English descriptors
- KwdEn :
- Animals, Anticoagulants (chemistry), Anticoagulants (isolation & purification), Anticoagulants (pharmacology), Anticoagulants (toxicity), Blood Coagulation (drug effects), Citrus sinensis (chemistry), Disease Models, Animal, Dose-Response Relationship, Drug, Factor Xa Inhibitors, Female, Fibrinolytic Agents (chemistry), Fibrinolytic Agents (isolation & purification), Fibrinolytic Agents (pharmacology), Fibrinolytic Agents (toxicity), Hemorrhage (chemically induced), Humans, Male, Molecular Weight, Pectins (chemistry), Pectins (isolation & purification), Pectins (pharmacology), Pectins (toxicity), Platelet Aggregation (drug effects), Rats, Rats, Wistar, Structure-Activity Relationship, Sulfates (chemistry), Sulfates (isolation & purification), Sulfates (pharmacology), Sulfates (toxicity), Thrombin (antagonists & inhibitors), Venous Thrombosis (blood), Venous Thrombosis (prevention & control).
- MESH :
- chemical , antagonists & inhibitors : Thrombin.
- chemical , chemistry : Anticoagulants, Fibrinolytic Agents, Pectins, Sulfates.
- chemical , isolation & purification : Anticoagulants, Fibrinolytic Agents, Pectins, Sulfates.
- chemical , pharmacology : Anticoagulants, Fibrinolytic Agents, Pectins, Sulfates.
- chemical , toxicity : Anticoagulants, Fibrinolytic Agents, Pectins, Sulfates.
- blood : Venous Thrombosis.
- chemically induced : Hemorrhage.
- chemistry : Citrus sinensis.
- drug effects : Blood Coagulation, Platelet Aggregation.
- prevention & control : Venous Thrombosis.
- Animals, Disease Models, Animal, Dose-Response Relationship, Drug, Factor Xa Inhibitors, Female, Humans, Male, Molecular Weight, Rats, Rats, Wistar, Structure-Activity Relationship.
Abstract
Evaluated were the anticoagulant and antithrombotic activities, and bleeding effect of two chemically sulfated polysaccharides, obtained from citric pectin, with different average molar masses. Both low-molecular-weight (Pec-LWS, 3,600 g/mol) and high-molecular-weight sulfated pectins (Pec-HWS, 12,000 g/mol) had essentially the same structure, consisting of a (1-->4)-linked alpha-D-GalpA chain with almost all its HO-2 and HO-3 groups substituted by sulfate. Both polysaccharides had anticoagulant activity in vitro, although Pec-HWS was a more potent antithrombotic agent in vivo, giving rise to total inhibition of venous thrombosis at a dose of 3.5 mg/kg body weight. Surprisingly, in contrast with heparin, Pec-HWS and Pec-LWS are able to directly inhibit alpha-thrombin and factor Xa by a mechanism independent of antithrombin (AT) and/or heparin co-factor II (HCII). Moreover, Pec-HWS provided a lower risk of bleeding than heparin at a dose of 100% effectiveness against venous thrombosis, indicating it to be a promising antithrombotic agent.
PubMed: 19404539
Links to Exploration step
pubmed:19404539Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.</title>
<author><name sortKey="Cipriani, Thales R" sort="Cipriani, Thales R" uniqKey="Cipriani T" first="Thales R" last="Cipriani">Thales R. Cipriani</name>
<affiliation><nlm:affiliation>Laboratório de Química de Carboidratos, Departamento de Bioquímica e Biologia Molecular, Universidade Federal do Paraná, CP 19046, CEP 81.531-980, Curitiba, PR, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gracher, Ana Helena P" sort="Gracher, Ana Helena P" uniqKey="Gracher A" first="Ana Helena P" last="Gracher">Ana Helena P. Gracher</name>
</author>
<author><name sortKey="De Souza, Lauro M" sort="De Souza, Lauro M" uniqKey="De Souza L" first="Lauro M" last="De Souza">Lauro M. De Souza</name>
</author>
<author><name sortKey="Fonseca, Roberto J C" sort="Fonseca, Roberto J C" uniqKey="Fonseca R" first="Roberto J C" last="Fonseca">Roberto J C. Fonseca</name>
</author>
<author><name sortKey="Belmiro, Celso L R" sort="Belmiro, Celso L R" uniqKey="Belmiro C" first="Celso L R" last="Belmiro">Celso L R. Belmiro</name>
</author>
<author><name sortKey="Gorin, Philip A J" sort="Gorin, Philip A J" uniqKey="Gorin P" first="Philip A J" last="Gorin">Philip A J. Gorin</name>
</author>
<author><name sortKey="Sassaki, Guilherme L" sort="Sassaki, Guilherme L" uniqKey="Sassaki G" first="Guilherme L" last="Sassaki">Guilherme L. Sassaki</name>
</author>
<author><name sortKey="Iacomini, Marcello" sort="Iacomini, Marcello" uniqKey="Iacomini M" first="Marcello" last="Iacomini">Marcello Iacomini</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19404539</idno>
<idno type="pmid">19404539</idno>
<idno type="wicri:Area/PubMed/Corpus">000960</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.</title>
<author><name sortKey="Cipriani, Thales R" sort="Cipriani, Thales R" uniqKey="Cipriani T" first="Thales R" last="Cipriani">Thales R. Cipriani</name>
<affiliation><nlm:affiliation>Laboratório de Química de Carboidratos, Departamento de Bioquímica e Biologia Molecular, Universidade Federal do Paraná, CP 19046, CEP 81.531-980, Curitiba, PR, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gracher, Ana Helena P" sort="Gracher, Ana Helena P" uniqKey="Gracher A" first="Ana Helena P" last="Gracher">Ana Helena P. Gracher</name>
</author>
<author><name sortKey="De Souza, Lauro M" sort="De Souza, Lauro M" uniqKey="De Souza L" first="Lauro M" last="De Souza">Lauro M. De Souza</name>
</author>
<author><name sortKey="Fonseca, Roberto J C" sort="Fonseca, Roberto J C" uniqKey="Fonseca R" first="Roberto J C" last="Fonseca">Roberto J C. Fonseca</name>
</author>
<author><name sortKey="Belmiro, Celso L R" sort="Belmiro, Celso L R" uniqKey="Belmiro C" first="Celso L R" last="Belmiro">Celso L R. Belmiro</name>
</author>
<author><name sortKey="Gorin, Philip A J" sort="Gorin, Philip A J" uniqKey="Gorin P" first="Philip A J" last="Gorin">Philip A J. Gorin</name>
</author>
<author><name sortKey="Sassaki, Guilherme L" sort="Sassaki, Guilherme L" uniqKey="Sassaki G" first="Guilherme L" last="Sassaki">Guilherme L. Sassaki</name>
</author>
<author><name sortKey="Iacomini, Marcello" sort="Iacomini, Marcello" uniqKey="Iacomini M" first="Marcello" last="Iacomini">Marcello Iacomini</name>
</author>
</analytic>
<series><title level="j">Thrombosis and haemostasis</title>
<idno type="ISSN">0340-6245</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Anticoagulants (chemistry)</term>
<term>Anticoagulants (isolation & purification)</term>
<term>Anticoagulants (pharmacology)</term>
<term>Anticoagulants (toxicity)</term>
<term>Blood Coagulation (drug effects)</term>
<term>Citrus sinensis (chemistry)</term>
<term>Disease Models, Animal</term>
<term>Dose-Response Relationship, Drug</term>
<term>Factor Xa Inhibitors</term>
<term>Female</term>
<term>Fibrinolytic Agents (chemistry)</term>
<term>Fibrinolytic Agents (isolation & purification)</term>
<term>Fibrinolytic Agents (pharmacology)</term>
<term>Fibrinolytic Agents (toxicity)</term>
<term>Hemorrhage (chemically induced)</term>
<term>Humans</term>
<term>Male</term>
<term>Molecular Weight</term>
<term>Pectins (chemistry)</term>
<term>Pectins (isolation & purification)</term>
<term>Pectins (pharmacology)</term>
<term>Pectins (toxicity)</term>
<term>Platelet Aggregation (drug effects)</term>
<term>Rats</term>
<term>Rats, Wistar</term>
<term>Structure-Activity Relationship</term>
<term>Sulfates (chemistry)</term>
<term>Sulfates (isolation & purification)</term>
<term>Sulfates (pharmacology)</term>
<term>Sulfates (toxicity)</term>
<term>Thrombin (antagonists & inhibitors)</term>
<term>Venous Thrombosis (blood)</term>
<term>Venous Thrombosis (prevention & control)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Thrombin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Anticoagulants</term>
<term>Fibrinolytic Agents</term>
<term>Pectins</term>
<term>Sulfates</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Anticoagulants</term>
<term>Fibrinolytic Agents</term>
<term>Pectins</term>
<term>Sulfates</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anticoagulants</term>
<term>Fibrinolytic Agents</term>
<term>Pectins</term>
<term>Sulfates</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en"><term>Anticoagulants</term>
<term>Fibrinolytic Agents</term>
<term>Pectins</term>
<term>Sulfates</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Venous Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Hemorrhage</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Citrus sinensis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Blood Coagulation</term>
<term>Platelet Aggregation</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Venous Thrombosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Dose-Response Relationship, Drug</term>
<term>Factor Xa Inhibitors</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Molecular Weight</term>
<term>Rats</term>
<term>Rats, Wistar</term>
<term>Structure-Activity Relationship</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Evaluated were the anticoagulant and antithrombotic activities, and bleeding effect of two chemically sulfated polysaccharides, obtained from citric pectin, with different average molar masses. Both low-molecular-weight (Pec-LWS, 3,600 g/mol) and high-molecular-weight sulfated pectins (Pec-HWS, 12,000 g/mol) had essentially the same structure, consisting of a (1-->4)-linked alpha-D-GalpA chain with almost all its HO-2 and HO-3 groups substituted by sulfate. Both polysaccharides had anticoagulant activity in vitro, although Pec-HWS was a more potent antithrombotic agent in vivo, giving rise to total inhibition of venous thrombosis at a dose of 3.5 mg/kg body weight. Surprisingly, in contrast with heparin, Pec-HWS and Pec-LWS are able to directly inhibit alpha-thrombin and factor Xa by a mechanism independent of antithrombin (AT) and/or heparin co-factor II (HCII). Moreover, Pec-HWS provided a lower risk of bleeding than heparin at a dose of 100% effectiveness against venous thrombosis, indicating it to be a promising antithrombotic agent.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19404539</PMID>
<DateCreated><Year>2009</Year>
<Month>4</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>06</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0340-6245</ISSN>
<JournalIssue CitedMedium="Print"><Volume>101</Volume>
<Issue>5</Issue>
<PubDate><Year>2009</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Thrombosis and haemostasis</Title>
<ISOAbbreviation>Thromb. Haemost.</ISOAbbreviation>
</Journal>
<ArticleTitle>Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.</ArticleTitle>
<Pagination><MedlinePgn>860-6</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Evaluated were the anticoagulant and antithrombotic activities, and bleeding effect of two chemically sulfated polysaccharides, obtained from citric pectin, with different average molar masses. Both low-molecular-weight (Pec-LWS, 3,600 g/mol) and high-molecular-weight sulfated pectins (Pec-HWS, 12,000 g/mol) had essentially the same structure, consisting of a (1-->4)-linked alpha-D-GalpA chain with almost all its HO-2 and HO-3 groups substituted by sulfate. Both polysaccharides had anticoagulant activity in vitro, although Pec-HWS was a more potent antithrombotic agent in vivo, giving rise to total inhibition of venous thrombosis at a dose of 3.5 mg/kg body weight. Surprisingly, in contrast with heparin, Pec-HWS and Pec-LWS are able to directly inhibit alpha-thrombin and factor Xa by a mechanism independent of antithrombin (AT) and/or heparin co-factor II (HCII). Moreover, Pec-HWS provided a lower risk of bleeding than heparin at a dose of 100% effectiveness against venous thrombosis, indicating it to be a promising antithrombotic agent.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cipriani</LastName>
<ForeName>Thales R</ForeName>
<Initials>TR</Initials>
<AffiliationInfo><Affiliation>Laboratório de Química de Carboidratos, Departamento de Bioquímica e Biologia Molecular, Universidade Federal do Paraná, CP 19046, CEP 81.531-980, Curitiba, PR, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gracher</LastName>
<ForeName>Ana Helena P</ForeName>
<Initials>AH</Initials>
</Author>
<Author ValidYN="Y"><LastName>de Souza</LastName>
<ForeName>Lauro M</ForeName>
<Initials>LM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fonseca</LastName>
<ForeName>Roberto J C</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Belmiro</LastName>
<ForeName>Celso L R</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gorin</LastName>
<ForeName>Philip A J</ForeName>
<Initials>PA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sassaki</LastName>
<ForeName>Guilherme L</ForeName>
<Initials>GL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Iacomini</LastName>
<ForeName>Marcello</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>ENG</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Thromb Haemost</MedlineTA>
<NlmUniqueID>7608063</NlmUniqueID>
<ISSNLinking>0340-6245</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D065427">Factor Xa Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010368">Pectins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013431">Sulfates</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.21.5</RegistryNumber>
<NameOfSubstance UI="D013917">Thrombin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D032084" MajorTopicYN="Y">Citrus sinensis</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065427" MajorTopicYN="N">Factor Xa Inhibitors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010368" MajorTopicYN="N">Pectins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010974" MajorTopicYN="N">Platelet Aggregation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013431" MajorTopicYN="N">Sulfates</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013917" MajorTopicYN="N">Thrombin</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19404539</ArticleId>
<ArticleId IdType="pii">09050860</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000960 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000960 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Bois |area= OrangerV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:19404539 |texte= Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:19404539" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a OrangerV1
![]() | This area was generated with Dilib version V0.6.25. | ![]() |